Immunotherapy!

What types of cancer is dostarlimab used for? The only overview you need.

Last updated: 05 February 2024

Since its first FDA approval in 2021, dostarlimab (commercially sold as Jemperli) has been in the media headlines a lot. Often, it's even been referred to as a "miracle drug" or "cancer cure"1,2.

Any cancer patient out there would like these headlines to be true, and we understand that. However, it's important to stay with the facts.

Immunotherapy drugs like dostarlimab aren't limited to specific tumor types. While the medicine is currently approved for treating endometrial cancer and some dMMR solid tumors, it might be applicable for more cancers in the future. Hopefully, also types of tumors beyond dMMR.

The wide variety of ongoing clinical trials involving dostarlimab vs Keytruda and other PD-1 inhibitors will provide more data on the medicine's future impact on cancer treatment. “everyone.org”